|
ZNF430 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.466000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.231000E-01 |
| Normal-vs-Stage2 |
3.076000E-01 |
| Normal-vs-Stage3 |
6.155800E-04 |
| Normal-vs-Stage4 |
4.061500E-03 |
| Stage1-vs-Stage2 |
5.471800E-01 |
| Stage1-vs-Stage3 |
1.037810E-03 |
| Stage1-vs-Stage4 |
1.046400E-02 |
| Stage2-vs-Stage3 |
2.029400E-01 |
| Stage2-vs-Stage4 |
2.898200E-01 |
| Stage3-vs-Stage4 |
8.379800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.629600E-02 |
| Normal-vs-AfricanAmerican |
2.269700E-02 |
| Normal-vs-Asian |
7.861800E-01 |
| Caucasian-vs-AfricanAmerican |
1.697360E-01 |
| Caucasian-vs-Asian |
4.066200E-01 |
| AfricanAmerican-vs-Asian |
2.524600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.030300E-02 |
| Normal-vs-Female |
5.354100E-02 |
| Male-vs-Female |
8.930600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.320360E-01 |
| Normal-vs-Age(41-60Yrs) |
2.617200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.319880E-02 |
| Normal-vs-Age(81-100Yrs) |
1.247890E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.845000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.553000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.886300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.208850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.503250E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.620000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.857400E-01 |
| Normal-vs-Grade 2 |
8.184400E-01 |
| Normal-vs-Grade 3 |
2.638200E-04 |
| Normal-vs-Grade 4 |
3.461000E-03 |
| Grade 1-vs-Grade 2 |
5.464200E-01 |
| Grade 1-vs-Grade 3 |
1.246310E-02 |
| Grade 1-vs-Grade 4 |
4.361800E-02 |
| Grade 2-vs-Grade 3 |
6.18079999999965E-05 |
| Grade 2-vs-Grade 4 |
4.556000E-03 |
| Grade 3-vs-Grade 4 |
7.516400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.539000E-01 |
| Normal-vs-ccB subtype |
8.320400E-02 |
| ccA subtype-vs-ccB subtype |
1.763830E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.001370E-01 |
| Normal-vs-N1 |
9.838400E-02 |
| N0-vs-N1 |
4.809200E-01 |
|
|
